Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Relyon plasma
Regensburg, Bavaria, Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
Relyon plasma’s devices and systems are commercially available and are used for surface treatment, sterilization, and disinfection; MediPlas Reactor achieves >6-log reduction in bacteria within minutes of treatment in medical and industrial contexts.
- Therapeutic areas
- ImmunologyInfectious DiseasesOtherNeurologyWomen's Health
- Modalities
- Device
- Industry
- Therapeutic Medical Devices
02
Partnerships
EPCOS AG (TDK Group)OTH Regensburg
Beyond the preview
Go deeper on Relyon plasma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Relyon plasma.